Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)
China flag China · Delayed Price · Currency is CNY
5.98
-0.48 (-7.43%)
Nov 17, 2026, 3:00 PM CST

Jiangsu Nanfang Medical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
19.5525.865095.67127.82152.82
Trading Asset Securities
22.522.522.5222.5221.2320
Cash & Short-Term Investments
42.0448.3572.53118.2149.04172.82
Cash Growth
-12.11%-33.33%-38.64%-20.70%-13.76%-46.86%
Accounts Receivable
98.8126.56124.98156.53170.34139.51
Other Receivables
2.153.335.419.6550.0713.6
Receivables
100.95129.9130.39166.18220.41153.11
Inventory
127.46138.82188.9267.58289.1216.81
Other Current Assets
4.384.938.4617.5819.7945.15
Total Current Assets
274.83322400.28569.54678.35587.89
Property, Plant & Equipment
425.58455.74496.51557.57632.16518.73
Long-Term Investments
62.7963.2263.1161.7260.5759.75
Other Intangible Assets
39.6240.7842.3339.6440.3736.18
Long-Term Deferred Tax Assets
39.8939.4348.3738.6336.8222.2
Long-Term Deferred Charges
4.315.834.875.436.959.07
Other Long-Term Assets
0.120.951.084.82.231.37
Total Assets
847.14927.941,0571,2771,4571,235

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
231.1245.8223.1215.41278.03170.86
Accrued Expenses
10.9616.6815.9310.7116.8315.24
Short-Term Debt
337.13344.95451.93452.03430.87352.23
Current Portion of Long-Term Debt
30.5335.0623.4516.4724.84-
Current Portion of Leases
--0.420.40.560.11
Current Income Taxes Payable
6.160.140.030.050.142.28
Current Unearned Revenue
10.698.75.316.135.244.72
Other Current Liabilities
10.2912.0520.0990.7251.1939.62
Total Current Liabilities
636.86663.38740.26791.92807.7585.06
Long-Term Debt
5273.8321.13-16.59-
Long-Term Leases
---0.420.641.45
Long-Term Unearned Revenue
7.467.948.587.588.068.55
Long-Term Deferred Tax Liabilities
0.791.052.163.192.982.93
Other Long-Term Liabilities
-0.57---0.9
Total Liabilities
697.12746.77772.14803.11835.96598.9

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
289.04289.04289.04292.47292.47292.47
Additional Paid-In Capital
106.24106.24106.24120.75120.75120.75
Retained Earnings
-247.1-218.1-116.3874.28221.7236.35
Treasury Stock
----18.6-18.6-18.6
Comprehensive Income & Other
--0.390.360.340.21
Total Common Equity
148.19177.19279.29469.27616.66631.18
Minority Interest
1.843.985.124.954.825.11
Shareholders' Equity
150.02181.17284.41474.22621.48636.3
Total Liabilities & Equity
847.14927.941,0571,2771,4571,235

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
419.66453.84496.93469.32473.5353.8
Net Cash (Debt)
-377.62-405.48-424.41-351.13-324.46-180.98
Net Cash Growth
------
Net Cash Per Share
-1.30-1.40-1.47-1.21-1.11-0.64
Filing Date Shares Outstanding
277.07289.04289.04292.47292.47292.47
Total Common Shares Outstanding
277.07289.04289.04292.47292.47292.47
Working Capital
-362.03-341.38-339.98-222.39-129.352.83
Book Value Per Share
0.530.610.971.602.112.16
Tangible Book Value
108.57136.41236.95429.63576.29595.01
Tangible Book Value Per Share
0.390.470.821.471.972.03
Buildings
-467.75457.79437.75420.73296.04
Machinery
-286.37288.77326.25325235.84
Construction In Progress
--7.228.6754.04114.65